| Literature DB >> 33858992 |
Hadar Israeli1,2, Oksana Degtjarik1, Fabrizio Fierro3,4, Vidicha Chunilal5, Amandeep Kaur Gill5, Nicolas J Roth5, Joaquin Botta5, Vadivel Prabahar1, Yoav Peleg6, Li F Chan5, Danny Ben-Zvi7, Peter J McCormick8, Masha Y Niv9,4, Moran Shalev-Benami10.
Abstract
Obesity is a global epidemic that causes morbidity and impaired quality of life. The melanocortin receptor 4 (MC4R) is at the crux of appetite, energy homeostasis, and body-weight control in the central nervous system and is a prime target for anti-obesity drugs. Here, we present the cryo-electron microscopy (cryo-EM) structure of the human MC4R-Gs signaling complex bound to the agonist setmelanotide, a cyclic peptide recently approved for the treatment of obesity. The work reveals the mechanism of MC4R activation, highlighting a molecular switch that initiates satiation signaling. In addition, our findings indicate that calcium (Ca2+) is required for agonist, but not antagonist, efficacy. These results fill a gap in the understanding of MC4R activation and could guide the design of future weight-management drugs.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33858992 DOI: 10.1126/science.abf7958
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728